Difemetorex

Difemetorex (INN), also known as diphemethoxidine, is a stimulant drug of the phenethylamine and piperidine classes that was developed in the 1960s but was never marketed. It is a norepinephrine-dopamine reuptake inhibitor with central nervous system (CNS) stimulating properties similar to amphetamines, although its pharmacological profile is somewhat different.

Pharmacology

Difemetorex acts primarily as a norepinephrine-dopamine reuptake inhibitor, increasing the levels of the neurotransmitters norepinephrine and dopamine in the synaptic cleft and leading to increased stimulation of the central nervous system. Unlike some other stimulants, which release stored monoamines, difemetorex inhibits their reuptake, prolonging their action.

Chemistry

Difemetorex is a member of the phenethylamine and piperidine chemical classes. Its chemical structure is related to other stimulant drugs such as amphetamine and methylphenidate, but it incorporates a piperidine ring, distinguishing it from the more common phenethylamine structure of amphetamines.

History

Developed in the 1960s, difemetorex was investigated for potential medical use, particularly in the treatment of obesity and attention deficit hyperactivity disorder (ADHD) due to its stimulant properties. However, due to concerns about its potential for abuse and adverse effects, it was never approved for medical use and did not reach the market.

Legal Status

The legal status of difemetorex varies by country, but it is generally classified as a controlled substance due to its similarity to other stimulant drugs, which are known to have a high potential for abuse and dependence.

Potential Uses and Research

While difemetorex itself is not used medically, research into its effects and mechanism of action has contributed to the understanding of stimulant drugs and their potential therapeutic applications. Studies on difemetorex and related compounds may inform the development of new treatments for conditions such as ADHD and narcolepsy, where stimulant medications are a key part of management.

See Also

• Stimulant
• Norepinephrine-dopamine reuptake inhibitor
• Phenethylamine
• Piperidine

References

‎ ‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian